R-FCM + maintenance R: Difference between revisions

From OncoWiki
Jump to navigationJump to search
(New page: == Regimen == R-FCM followed by Rituximab 375 mg/m2 iv qw x 4 doses at 3 and 9 months == References == [http://www.bloodjournal.org/cgi/content/abstract/108/13/4003 Forstpointner R e...)
 
m (1 revision)
 
(No difference)

Latest revision as of 02:18, 7 February 2012

Regimen

R-FCM followed by Rituximab 375 mg/m2 iv qw x 4 doses at 3 and 9 months

References

Forstpointner R et al. Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). Blood 2006; 108:4003

Retrieved from "http://oncowiki.info/index.php?title=R-FCM_%2B_maintenance_R&oldid=575"